Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction (2005)
- Authors:
- USP affiliated authors: NOGUEIRA, ANTONIO ALBERTO - FMRP ; FERRIANI, RUI ALBERTO - FMRP
- Unidade: FMRP
- Subjects: INFERTILIDADE FEMININA; REPRODUÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of Reproductive Medicine
- ISSN: 0024-7758
- Volume/Número/Paginação/Ano: v. 50, n. 7, p. 501-506, 2005
-
ABNT
SILVA, Ana Carolina Japur de Sá Rosa e et al. Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction. Journal of Reproductive Medicine, v. 50, n. 7, p. 501-506, 2005Tradução . . Acesso em: 27 dez. 2025. -
APA
Silva, A. C. J. de S. R. e, Silva, J. C. R. e, Reis, F. J., Nogueira, A. A., & Ferriani, R. A. (2005). Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction. Journal of Reproductive Medicine, 50( 7), 501-506. -
NLM
Silva ACJ de SR e, Silva JCR e, Reis FJ, Nogueira AA, Ferriani RA. Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction. Journal of Reproductive Medicine. 2005 ; 50( 7): 501-506.[citado 2025 dez. 27 ] -
Vancouver
Silva ACJ de SR e, Silva JCR e, Reis FJ, Nogueira AA, Ferriani RA. Routine office hysteroscopy in the investigation of infertile couples before assisted reproduction. Journal of Reproductive Medicine. 2005 ; 50( 7): 501-506.[citado 2025 dez. 27 ] - Effects of the levonorgestrel releasing intra-uterine system on uterine and ovarian volumes, endometrial thickness and dopplervelocimetry of uterine arteries, in women with pelvic endometriosis
- The levonorgestrel releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis
- Levonorgestrel intra-uterine device (Lng-IUD) reduces CA-125 serum levels in patients with pelvic endometriosis
- Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Use of levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Increased expression of ID2, PRELP and SMOC2 genes in patients with endometriosis
- Tuberculose genital e amenorreia primaria: descricao de caso
- Use of the levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas
- Valor do CA-125 para diagnóstico de estágios avançados de endometriose
- Using a search-volume tool (Google Trends) to assess global interest for uterine fibroids
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
